Kallikrein-related peptidases Volume 1, Characterization, regulation, and interactions within the protease web /
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Ētahi atu kaituhi: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Berlin :
Walter de Gruyter,
c2012.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- Genomic structure of the KLK locus
- Single nucleotide polymorphisms in the human KLK locus and their implication in various diseases
- Evolution of Kallikrein-related peptidases
- Structural aspects of Kallikrein-related peptidases
- Molecular recognition properties of Kallikrein-related peptidases on synthetic and endogenous substrates
- Natural, engineered, and synthetic inhibitors of Kallikrein-related peptidases
- Kallikrein-related peptidases as pharmaceutical targets
- Expression of Kallikrein-related peptidases under (patho) physiological conditions
- Kallikrein-related peptidases within the proteolytic web
- Kallikrein-Kinin cascade: bioregulation by human tissue kallikrein 1 (HK1, KLK 1)
- Role of KLK4 in dental enamel formation.
- Kallikrein-related peptidases and semen
- Kallikrein-related peptidases and inhibitors of the skin
- Physiological and pathophysiological roles of Kallikrein-related peptidases in the central nervous system
- Kallikrein-related peptidases (KLKS), proteinase-mediated signaling and proteinase-activated receptors (PARS)
- Pathophysiology of Kallikrein-related peptidases in lung cancer
- Clinical relevance of Kallikrein-related peptidases in gastric and colorectal cancer
- Pathophysiology of Kallikrein-related peptidases in head and neck cancer
- PSA (prostate-specific antigen) and other Kallikrein-related peptidases in prostate cancer
- Cellular model systems to study the tumor biological role of Kallikrein-related peptidases in ovarian and prostate cancer
- Clinical relevance of Kallikrein-related peptidases in breast cancer
- Clinical relevance of Kallikrein-related peptidases in ovarian cancer
- MicroRNAs : a new control mechanism for Kallikrein-related peptidases in kidney and other cancers
- Genomic instability of the KLK-locus in cancer
- Kallikrein-related peptidases as biomarkers in personalized cancer medicine.